Systems biology describes the collection of a set of measurements on a system, integrated with a mathematical model of that system. The model and the measurements must be made together and refined iteratively, requiring close collaboration between biologists and modellers. A complete cell is probably too large and complicated to model yet, but simplified subsystems will probably produce valuable results. I consider various ways of simplifying the system and conclude that the biggest challenge is to get everyone working together productively.
Systems biology
There are many different definitions of systems biology, which is in danger of becoming something of a buzzword, the kind of thing one might write in grant applications or in papers without meaning anything much. The number of publications using the phrase 'systems biology' has increased significantly over the last 2 years ( Figure 1 ). The term is therefore in danger of losing its meaning. Systems biology is more than just a set of observations on a system; in addition to this, it must at least contain a mathematical or computer model of the system. There seems little point in having a mathematical model if that model does not tell us something useful about the system; in other words, the model should be able to provide predictions about the behaviour of the system. It would be unusual to find scientists equally at home with both high-throughput analysis of biological data and the construction of mathematical models: systems biology is thus usually carried out as an interdisciplinary project involving biologists and computer scientists -two groups of scientists who do not normally speak the same language, work in the same way or in the same building or have the same funding requirements. In this paper, I discuss the kind of details needed and how close we may be to achieving our aim.
The components of the system
The explicit target of several systems biology programmes is to model a cell, typically seen as a prokaryotic cell. Thus we have programmes aimed at the E-cell [1] and the Silicon Cell [2] . A standard prokaryotic cell contains approx. 5000 genes. This is too large a number to be able to model explicitly (which we may not necessarily want to do, as described below). At any one time, the cell will be expressing only perhaps half of these genes. Moreover, under ideal conditions of a rich medium, steady-state growth and no competition, a prokaryotic cell seems to be able to get by with only approx. 300 genes [3, 4] . We can therefore suggest a round-number minimum figure of approx. 500 genes to be required for a more typical bacterial lifestyle. Most of the gene products are proteins and most of the proteins are enzymes. We thus have approx. 400 enzymes to deal with and 100 other assorted structural, transport and regulatory proteins and RNA molecules. All of the genes will be subject to some kind of regulation, be it transcriptional, translational or posttranslational. This effectively means that almost every gene has a unique regulatory control, probably by several different factors, even if it is part of an operon or regulon. Although this information can be obtained quantitatively in highthroughput experiments [5] , it is far from trivial to do.
As another gross approximation, let us assume that there are roughly 1000 different types of small molecules in and around the cell, consisting mainly of metabolic intermediates and products. Many of these in our minimal cell will be supplied from outside and transported into the cell: indeed, in a typical animal cell, a high proportion of intracellular metabolites are xenobiotics [6] .
Thus, to be able to model the cell, we require details of the rates for approx. 400 enzymes, probably described by Michaelis-Menten parameters K m and V max , and to know how these parameters are affected by activators or inhibitors, including the 1000 small molecules present or any of the Figure 1 The number of publications using the phrase 'systems biology' (SB) since 1996 either in the title (grey) or in the abstract and key words (white). macromolecules present. Such details are particularly important when it comes to the more complex reactions that a cell has to perform, such as transcription and translation. And of course, many enzymes are regulated not only by the binding of small molecules, but also by the binding of other proteins, by covalent modification (including modifications that do not affect the activity but do change the location of the protein) or by degradation [7] .
My point is that we do not know nearly enough about most enzymes in the cell to even hazard a guess about the rates of most of them. For nearly all of the metabolic enzymes, we know the reactions they catalyse and, for a reasonably large proportion, we know or could guess the kinetic parameters and main activators or inhibitors. We are however largely ignorant of most of the other control elements. For many of the regulatory enzymes, we do not even know the substrates. There is however a major difficulty, in that what we know about enzymes comes largely from studies of purified enzymes in vitro. We know much less about how enzymes behave in vivo. Inside the cell, the very high level of macromolecular crowding affects enzyme activity probably by factors of 2-10 [8] . Enzymes probably clump together in 'metabolons' [9] , leading to unknown regulatory control and a probable large enhancement of the rate for a series of metabolic reactions, not least through metabolic channelling. Moreover, we know that the very high concentrations inside the cell restrict the rate of diffusion of small molecules (by a factor of 2-5?) and of macromolecules (by a much larger factor). This presumably acts to slow down reactions, although the evidence is by no means clear.
A further complication comes from the fact that molecules are not randomly distributed inside a cell, implying that local concentrations could be very different from the average [10] . Proteins, DNA and RNA clearly move around as the cell grows. These movements are of course regulated, and again, we are ignorant of the regulatory mechanisms in many cases.
I submit that all of this means that, for most enzymes, we cannot guess their actual rates inside the cell even within an order of magnitude and there are very few for which we have a complete list of all the factors that regulate their activity. There are so many unknowns that it seems we are condemned to spend many years collecting data before we can even start to think about modelling what is going on: systems biology will be barely off the starting line for the foreseeable future. Moreover, consider the complexity of modelling this system even if we knew everything about it. At least 1000 coupled differential equations would be needed and at least some of them will need to be solved every second or less, over a period of hours (if we hope to model, for example, a complete cell cycle). This is, to say the least, challenging. Hence the question in the title of this paper: will it work?
Simplifying the system I believe the analysis given above demonstrates that a complete model (meaning one that models the behaviour of every component simultaneously) is well beyond our reach: indeed, to such an extent beyond our reach that if this is what systems biology means, we may as well go home now. In order to simplify the problem, what can we miss out without seriously damaging the model?
Many metabolic pathways run at broadly the same rate over a very wide range of conditions: this is one of the things that make biological systems 'robust' [11] . Metabolic control analysis provides more insight into this robustness and shows how the pathways can be largely self-compensatory [12] . This must mean that, over a wide range of conditions, we can treat many pathways as 'black boxes', so that we do not need to worry about what is going on inside; we just need to model input (metabolites and control signals) with a limited range of outputs (Figure 2 ). Biological systems are reasonably modular, so there is, in general, little cross-talk between black boxes [11] . The skill, of course, lies in knowing to which pathways we can do this and how much we can limit the outputs. Clearly, this is primarily a job for the modellers, but one requiring interdisciplinary interaction. A different kind of simplification comes from the fact that many gene products seem to be redundant in real systems. Therefore it is possible to miss out many of the components and still achieve a functional system [13] . The results of such an analysis should provide the biologists with new insights into the system and this of course is one of the main goals of systems biology [10] .
One could even venture out from the single-celled system to something much more complex by judicious choice of black boxes, to construct a hierarchy of systems, each at different levels of approximation. This is essentially what physiology has been doing for years. We can for example model a set of cells, where the inner workings of a cell do not need to be considered in detail and we are only concerned with how the output varies in response to differing input: for example, a blood vessel, a neuron or even a heart [14] . And then, the complete body is a further level of abstraction, where each of the constituent organs is again treated largely as a black box responding to the needs of the system as a whole.
Another way of simplifying the system is to make it smaller (Figure 2c ). Despite the fact that most effort in (so-called) systems biology has concentrated on large and complex disease models, arguably the biggest success in systems biology proper has come from looking at signalling pathways, where the total number of components is manageably small and the output at least is often simple and easily quantifiablethe regulation of transcription of a gene or set of genes [15] . There are many other simplified systems one could imagine: for example, a mitochondrion or even a mitochondrial inner membrane, or the metabolism of a small molecule such as galactose [16] . Although such studies are under way, it is probably fair to say that here we are still at the data-gathering stage.
Realization of systems biology
What do we need to do to construct a model? Clearly, we need data. How much and what kind of data? This of course depends on how detailed a model we want to build and how many black boxes it should contain. Here, I come back to the principle with which I started, that the model should be able to generate predictions. Ideally, my model should be capable of predicting what happens if I knock out a gene or add glucose or cyanide to the medium. To do this, it needs to be a fairly detailed model, at least at the level of detail of having genes or having enzymes that respond to glucose or cyanide. It is not practical in the early stages (which is certainly where we are now) to build comprehensive models: it is only reasonable to expect that the model can predict something that it was designed to predict. (The logical corollary of this statement is that general, systems biology models of the whole cell are not yet practical. Thus an answer to the question in the title is 'yes, as long as the system is simple enough'.) Thus our model might, for example, describe the glycolytic pathway and contain all the genes, enzymes and control elements of the glycolytic pathway. In this case, it would be reasonable to ask what would happen if I mutate an enzyme to decrease its activity by 50% or add 3-phosphoglycerate to the cell, and it would not be reasonable to ask what would be the effect of changing the intracellular pH, unless this was a feature specifically designed in the model. This therefore implies that there needs to be a close working relationship between the scientists obtaining the data and the scientists constructing the model. It has to be a team effort, and it will not work if one half or the other is bolted on later. Therefore there has to be an agreement, from the start, as to what the model will be able to predict, and there need to be detailed discussions as to what information is needed; for example, do we need to know the transcriptome and the proteome? Do we also need to know the metabolome? How quantitative and reproducible should the data be? This should be agreed upon at the start, because it will have a major effect on the way the data are obtained and the time taken to accumulate reliable data. It is not reasonable to expect the modellers to know what to expect in a biological system: it is therefore up to the biologists to devise experimental methods that uncover the important gene products and their regulatory elements. They therefore need to carry out suitable perturbations to the system, for example by systematically knocking out selected genes.
Several studies have shown that it is vital that the biologists use a system that is reproducible: that is, one where the same results are obtained each time. There is thus a vital need for standardization in the biological systems used, just as there is in the databases and coding structures used by the modellers (a problem that needs to be solved urgently if we are to avoid a large waste of effort) [17] .
Most of all, it is absolutely necessary for the biologists and the modellers to make real efforts to understand each others' work: not to be disdainful and suspicious but to want to learn -possibly even to try their hands at running a gel or writing a macro [18, 19] . The academic system does not encourage such ways of working. For systems biology to be successful, this is probably the biggest challenge of all.
